Viking Therapeutics, Inc. (VKTX)

Last Year

07-May-23 -- 06-May-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

11

0

2

+1

0

+2

0

+3

Two Year Chart

07-May-22 -- 06-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
27-Mar-24 8:51 PM View:	27-Mar-24 Payment of Exercise ($12.83M)	Lian Brian President & CEO Director		Viking Therapeutics, Inc. - VKTX	3% 2.21M to 2.27M	0	0	--	--	Show Txns Hide Txns

18-May-23 6:30 PM View:	16-May-23 Planned Option Sale ($384.00K)	MacArtney Lawson Director		Viking Therapeutics, Inc. - VKTX	0% 47.97K	0	0	--	--	Show Txns Hide Txns

18-May-23 6:31 PM View:	16-May-23 Planned Option Sale ($1,000.00K)	Rowland Charles A Jr Director		Viking Therapeutics, Inc. - VKTX	0% 30.0K	0	0	--	--	Show Txns Hide Txns

08-Feb-24 7:38 PM View:	08-Feb-24 Planned Option Sale ($701.25K)	Rouan Sarah Kathryn Director		Viking Therapeutics, Inc. - VKTX	0% --	0	0	--	--	Show Txns Hide Txns

02-May-24 9:27 PM View:	01-May-24 Planned Option Sale ($22.14M)	Mancini Marianna Chief Operating Officer		Viking Therapeutics, Inc. - VKTX	17% 298.87K to 348.51K	0	0	--	--	Show Txns Hide Txns

03-May-24 8:51 PM View:	03-May-24 Sale (Planned) ($2.43M)	Zante Greg Chief Financial Officer		Viking Therapeutics, Inc. - VKTX	9% 160.39K to 174.85K	0	0	--	--	Show Txns Hide Txns